Select Bibliography

Select Bibliography

Filter by any of these (after searching):

Federally Funded Research

There are 59 items

A phase 3 study of androgen annihilation in high-risk biochemically relapsed prostate cancer: an Alliance Foundation trial (AFT-19)

DOI

Google Scholar

Aggarwal, Rahul , Eggener, Scott , Chen, Ronald , Heller, Glenn ... - ASCO - J Clin Oncol - 2018

Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - GU - AFT-19

Alliance A031501: Phase III Randomized Adjuvant Study of MK-3475 (Pembrolizumab) in Muscle Invasive and Locally Advanced Urothelial Carcinoma (MIBC) (AMBASSADOR) vs Observation

Google Scholar

Apolo, Andrea , Rosenberg, Jonathan , Morris, Michael ... - ASCO GU - J Clin Oncol - 2019

Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - GU - A031501

Cancer and Leukemia Group B studies of recombinant Interleukin-2 maintenance therapy in acute myeloid leukemia

Google Scholar

Baer, M. R. , Kolitz, J. E. , George, S. L. , Caligiuri, M. A. ... - - Ann Hematol - 2008

Abstract - No-Endpoint Endpoint - Comprehensive Analysis - Leukemia - CALGB-19808

Challenges for conducting clinical trials evaluating maintenance chemotherapy in acute myeloid leukemia (AML): a Cancer and Leukemia Group B (CALGB) study

Google Scholar

Blum, W. , Donohue, K. , Marcucci, G. , Deangelo, D. J. , Uy, G. L. ... - ASH - Blood - 2010

Abstract - No-Endpoint Endpoint - Comprehensive Analysis - Leukemia - CALGB-10503

Development of Clinical Precision Medicine Approaches in Meningiomas: Alliance A071401.

Google Scholar

Brastianos, Priscilla , Shi, Qian , Santagata, Sandro ... - SNOM - - 2016

Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - Neuro-Onc - A071401

Teaching Health-Care Providers to Query Patients With Cancer About Sexual and Gender Minority (SGM) Status and Sexual Health

PubMed

PMC

QxMD

DOI

Google Scholar

Cathcart-Rake, Elizabeth J. , Breitkopf, Carmen Radecki ... - - Am J Hosp Palliat Care - 2019

Manuscript - No-Endpoint Endpoint - Trial-Description-Only Analysis - Disparities - Pilot

How (and why) to ask the older cancer patient about sexual health and sexual minority status.

PubMed

DOI

Google Scholar

Cathcart-Rake, Elizabeth , O'Connor, Jennifer M , Jacobson, Alison ... - - J Geriatr Oncol - 2019

Manuscript - No-Endpoint Endpoint - Other Analysis - Disparities - Pilot

Innovative estimation of survival using log-normal survival modelling on ACCENT database

PubMed

PMC

QxMD

DOI

Google Scholar

Chapman, J W , O'Callaghan, C J , Hu, N , Ding, K , Yothers, G A ... - - Br. J. Cancer - 2013

Manuscript - No-Endpoint Endpoint - Primary Analysis - GI - N0441

Methodological Considerations in the Design and Implementation of Clinical Trials

PubMed

PMC

QxMD

DOI

Google Scholar

Cirrincione, Constance T. , Lavoie Smith, Ellen M. ... - - Semin Oncol Nurs - 2014

Manuscript - No-Endpoint Endpoint - Other Analysis - Onc Nursing - Pilot

Validity and Reliability of the U.S. National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

PubMed

PMC

QxMD

DOI

Google Scholar

Dueck, Amylou C. , Mendoza, Tito R. , Mitchell, Sandra A. ... - - JAMA Oncol - 2015

Manuscript - No-Endpoint Endpoint - Primary Analysis - Health Outcome - Comprehensive

American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021: A randomized study of sublobar resection compared with stereotactic body radiotherapy for high-risk stage I non–small cell lung cancer

PubMed

PMC

QxMD

DOI

Google Scholar

Fernando, Hiran C. ... - - J. Thorac. Cardiovasc. Surg. - 2012

Manuscript - No-Endpoint Endpoint - Trial-Description-Only Analysis - Respiratory - ACOSOG-Z4099

ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early Stage Non–Small Cell Lung Cancer

PubMed

PMC

QxMD

DOI

Google Scholar

Govindan, Ramaswamy , Mandrekar, Sumithra J. , Gerber, David E. ... - - Clin. Cancer Res. - 2015

Manuscript - No-Endpoint Endpoint - Trial-Description-Only Analysis - Respiratory - A151216

Optimal Two-Stage Dynamic Treatment Regimes from a Classification Perspective with Censored Survival Data

PubMed

PMC

QxMD

DOI

Google Scholar

Hager, Rebecca , Tsiatis, Anastasios A. ... - - Biometrics - 2018

Manuscript - No-Endpoint Endpoint - Comprehensive Analysis - Leukemia - C9710

N0733: Phase II trial of capecitabine and lapatinib +/- cixutumumab in HER2 positive breast cancer

Google Scholar

Haluska, P. , Reinholz, M. M. , Dueck, A. C. , Linden, H. M. ... - - J. Clin. Oncol. - 2010

Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - Breast - N0733

Public Health and Cooperative Group Partnership: A Colorectal Cancer Educational Intervention for Breast Cancer Survivors

PubMed

PMC

QxMD

DOI

Google Scholar

Homan ... - - Semin Oncol Nurs - 2014

Manuscript - No-Endpoint Endpoint - Comprehensive Analysis - Onc Nursing - A21_011

A phase II study evaluating the role of sentinel lymph node surgery and axillary lymph node dissection following preoperative chemotherapy in women with node-positive breast cancer (T1-4, N1-2, M0) at initial diagnosis: ACOSOG Z1071

Google Scholar

Hunt, K. , Le-Petross, H. T. , Suman, V. , Haffty, B. G. ... - - J. Clin. Oncol. - 2010

Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - Breast - ACOSOG-Z1071

The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)

PubMed

PMC

QxMD

DOI

Google Scholar

Hwang, E Shelley , Hyslop, Terry , Lynch, Thomas , Frank, Elizabeth ... - - BMJ Open - 2019

Manuscript - No-Endpoint Endpoint - Trial-Description-Only Analysis - ACS CCDRC - AFT-25

The role of patient advocates in clinical trials: Perspectives from investigators and advocates in the Cancer and Leukemia Group B (CALGB)

Google Scholar

Katz, M. L. , Archer, L. E. , Peppercorn, J. M. , Kereakoglow, S. ... - - J. Clin. Oncol. - 2010

Abstract - No-Endpoint Endpoint - Primary Analysis - Patient Adv - Comprehensive

Alliance for clinical trials in oncology (ALLIANCE) trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas

PubMed

PMC

QxMD

DOI

Google Scholar

Katz, Matthew H. G. , Ou, Fang-Shu , Herman, Joseph M. ... - - BMC Cancer - 2017

Manuscript - No-Endpoint Endpoint - Trial-Description-Only Analysis - GI - A021501

Borderline resectable pancreatic cancer: Need for Standardization and Methods for Optimal Clinical Trial Design

PubMed

PMC

QxMD

DOI

Google Scholar

Katz, Matthew HG , Marsh, Robert , Herman, Joseph M. , Shi, Qian ... - - Ann. Surg. Oncol. - 2013

Manuscript - No-Endpoint Endpoint - Comprehensive Analysis - GI - A021101

Alliance for clinical trials in oncology trial A021501: preoperative extended chemotherapy vs. chemotherapy plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the head of the pancreas

Google Scholar

Katz, Matthew , Herman, Joseph M. , Ou, Fang-Shu , Marsh, Robert ... - ASCO - J. Clin. Oncol. - 2017

Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - GI - A021501

Nursing contributions in Community Clinical Oncology Research Programs.

PubMed

DOI

Google Scholar

Klinger, Kathy , Figueras, Cesar , Beney, Kathleen M , Armer, Jane M ... - - Semin Oncol Nurs - 2014

Manuscript - No-Endpoint Endpoint - Comprehensive Analysis - Onc Nursing -

Nursing's presence in the changing cooperative group setting.

PubMed

DOI

Google Scholar

Kottschade, Lisa A , Bell, Jennifer , Klinger, Kathy ... - - Semin Oncol Nurs - 2014

Manuscript - No-Endpoint Endpoint - Comprehensive Analysis - Onc Nursing -

Application of multi-state models in cancer clinical trials

PubMed

PMC

QxMD

DOI

Google Scholar

Le-Rademacher, Jennifer G , Peterson, Ryan A , Therneau, Terry M ... - - Clin Trials - 2018

Manuscript - No-Endpoint Endpoint - Other Analysis - Leukemia - A151732 , CALGB-10603

Alliance A051202: A Phase I Trial of Lenalidomide, Rituximab and GS-1101 (Idelalisib) in recurrent follicular lymphoma

DOI

Google Scholar

Leonard, John P. , Jung, Sin-ho ... - ICML - Hematol Oncol - 2013

Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - Lymphoma - A051202

The nurse liaison role in the cooperative group setting.

PubMed

DOI

Google Scholar

Levy, Sharon , Klinger, Kathy , Galinsky, Ilene , DeKrey, Wanda ... - - Semin Oncol Nurs - 2014

Manuscript - No-Endpoint Endpoint - Comprehensive Analysis - Onc Nursing -

The Breast Cancer Weight Loss (BWEL) Trial: Randomized Phase III Trial Evaluating The Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer (Alliance A011401)

Google Scholar

Ligibel, Jennifer A. , Barry, William T. , Alfano, Catherine ... - ASCO - J Clin Oncol - 2018

Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - Breast - A011401

Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design

PubMed

PMC

QxMD

DOI

Google Scholar

Ligibel, Jennifer A. , Barry, William T. , Alfano, Catherine ... - - NPJ Breast Cancer - 2017

Manuscript - No-Endpoint Endpoint - Trial-Description-Only Analysis - Breast - A011401

A randomized phase ii study of anti-PD-1 antibody [MK-3475 (pembrolizumab)] alone versus anti-PD1 antibody plus stereotactic body radiation therapy in advanced merkel cell carcinoma (Alliance A091605)

DOI

Google Scholar

Luke, Jason , Chmura, Steven , Salama, Joseph , Al-Hallaq, Hania ... - ASCO - J Clin Oncol - 2018

Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - Experimental - A091605

Alliance A011106: ALTernate approaches for clinical stage II or III Estrogen Receptor positive breast cancer NeoAdjuvant TrEatment (ALTERNATE) in postmenopausal women: A Phase III Study

Google Scholar

Ma, Cynthia X. , Suman, Vera , Leitch, A. Marilyn , Sanati, Souzan ... - SABCS - Cancer Res. - 2015

Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - Breast - A011106

Quality assessment metrics for whole genome gene expression profiling of paraffin embedded samples

PubMed

PMC

QxMD

Google Scholar

Mahoney, D. W. , Therneau, T. M. , Anderson, S. K. , Jen, J. ... - - BMC Res Notes - 2013

Manuscript - No-Endpoint Endpoint - Primary Analysis - PPP - N9831

Combining Survival and Toxicity Effect Sizes from Clinical Trials: NCCTG 89-20-52 (Alliance)

PubMed

PMC

QxMD

DOI

Google Scholar

Major-Elechi, Brittny T. , Novotny, Paul J. , Singh, Jasvinder A. ... - - Int J Stat Med Res - 2018

Manuscript - No-Endpoint Endpoint - Other Analysis - Health Outcome - NCCTG-89-20-52

Impact of disease progression (DP) date determination method on post progression survival (PPS) and DP metrics in advanced lung cancer

Google Scholar

Mandrekar, Sumithra J. , Foster, Nathan R. , Qi, Yingwei ... - ASCO - J. Clin. Oncol. - 2012

Abstract - No-Endpoint Endpoint - Comprehensive Analysis - Respiratory - N0424

How Much Missing Data is Too Much? Monte Carlo Simulations to Develop SISAQOL Guidelines for Missing Data Handling.

Google Scholar

Mazza, Gina L. , Coens, Corneel , Pe, Madeline , Dorme, Lien ... - ISOQOL - Qual Life Res - 2018

Abstract - No-Endpoint Endpoint - Other Analysis - Health Outcome -

Central review of cytogenetics is necessary for cooperative group correlative and clinical studies of adult acute leukemia: The Cancer and Leukemia Group B experience

PubMed

PMC

QxMD

Google Scholar

Mrózek, Krzysztof , Carroll, Andrew J. , Maharry, Kati ... - - Int. J. Oncol. - 2008

Manuscript - No-Endpoint Endpoint - Comprehensive Analysis - Leuk Corr Sci - CALGB-8461

Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

PubMed

PMC

QxMD

DOI

Google Scholar

Mrózek, Krzysztof , Marcucci, Guido , Paschka, Peter ... - - Blood - 2007

Manuscript - No-Endpoint Endpoint - Comprehensive Analysis - Leuk Corr Sci - Comprehensive

Milestone prediction for time-to-event endpoint monitoring in clinical trials

PubMed

PMC

QxMD

DOI

Google Scholar

Ou, Fang-Shu , Heller, Martin ... - - Pharm Stat - 2019

Manuscript - No-Endpoint Endpoint - Other Analysis - GI - A151730

The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD

PubMed

PMC

QxMD

DOI

Google Scholar

Pacyna, Joel E. , Kim, Simon , Yost, Kathleen , Sedlacek, Hillary ... - - BMC Cancer - 2018

Manuscript - No-Endpoint Endpoint - Trial-Description-Only Analysis - ACS CCDRC - A191402CD

Lessons learned from implementing the first Alliance NCORP Research Base Cancer Care Delivery Research (CCDR) trial A191402CD

Google Scholar

Pacyna, Joel E. , Sloan, Jeff , Kim, Simon , Sedlacek, Hillary ... - ASCO QCS - J Clin Oncol - 2018

Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - Disparities - A191402CD

Prognostic Model for Mesothelioma Based on Cancer and Leukemia Group B (CALGB) Trials (Alliance)

Google Scholar

Pang, Herbert , Yan, Kang , Kratzke, Robert , Stinchcombe, Thomas ... - IASLC (WCLC) - J Thorac Oncol - 2017

Abstract - No-Endpoint Endpoint - Comprehensive Analysis - Respiratory - CALGB-30101 , CALGB-30107 , CALGB-30307 , CALGB-30601 , CALGB-39807 , CALGB-8435 , CALGB-8638 , CALGB-8833 , CALGB-8933 , CALGB-9031 , CALGB-9131 , CALGB-9234 , CALGB-9530 , CALGB-9631 , CALGB-9733

A Randomized Trial of Diet in Men with Early Stage Prostate Cancer on Active Surveillance: Rationale and Design of the Men’s Eating and Living (MEAL) Study (CALGB 70807 [Alliance])

PubMed

PMC

QxMD

DOI

Google Scholar

Parsons, J. Kellogg , Pierce, John P. , Mohler, James ... - - Contemp Clin Trials - 2014

Manuscript - No-Endpoint Endpoint - Trial-Description-Only Analysis - Prevention - CALGB-70807

Improving standards of patient reported outcomes analysis: developing a consensus taxonomy of key research objectives – a SISAQOL initiative

Google Scholar

Pe , M. , L., Dorme , C., Coens , E., Basch , Melanie, Calvert ... - ISOQOL - Qual Life Res - 2018

Abstract - No-Endpoint Endpoint - Other Analysis - Health Outcome -

Ethics of Mandatory Research Biopsy for Correlative End Points Within Clinical Trials in Oncology

PubMed

PMC

QxMD

DOI

Google Scholar

Peppercorn, Jeffrey , Shapira, Iuliana , Collyar, Deborah ... - - J. Clin. Oncol - 2010

Manuscript - No-Endpoint Endpoint - Comprehensive Analysis - Ethics -

Tobacco Assessment in Completed Lung Cancer Treatment Trials

PubMed

PMC

QxMD

DOI

Google Scholar

Peters, Erica N. , Warren, Graham W. , Sloan, Jeff A. ... - - Cancer - 2016

Manuscript - No-Endpoint Endpoint - Comprehensive Analysis - Prevention - Comprehensive

Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: Design of the TEXT and SOFT trials

PubMed

PMC

QxMD

DOI

Google Scholar

Regan, Meredith M. , Pagani, Olivia , Fleming, Gini F. ... - - Breast - 2013

Manuscript - No-Endpoint Endpoint - Trial-Description-Only Analysis - Breast - IBCSG-24-02 (SOFT-TEXT)

Cancer and Leukemia Group B Pathology Committee Guidelines for Tissue Microarray Construction Representing Multicenter Prospective Clinical Trial Tissues

PubMed

PMC

QxMD

DOI

Google Scholar

Rimm, David L. , Nielsen, Torsten O. , Jewell, Scott D. ... - - J Clin Oncol - 2011

Manuscript - No-Endpoint Endpoint - Comprehensive Analysis - Pathology - C9741 , CALGB-9840

Phase II Trial of Atezolizumab Before and After Definitive Chemoradiation for Patients with Unresectable Stage III NSCLC

Google Scholar

Ross, Helen J. , Kozono, David , Urbanic, James , Williams, Terence ... - IASLC (WCLC) - J Thorac Oncol - 2017

Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - Respiratory - AFT-16

Application of a sequential multiple assignment randomized trial (SMART) design in older patients with chronic lymphocytic leukemia

PubMed

PMC

QxMD

DOI

Google Scholar

Ruppert, A S , Yin, J , Davidian, M , Tsiatis, A A , Byrd, J C ... - - Ann. Oncol - 2019

Manuscript - No-Endpoint Endpoint - Other Analysis - Leukemia - A041202

End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group.

PubMed

DOI

Google Scholar

Sargent, Daniel J , Patiyil, Smitha , Yothers, Greg ... - - J. Clin. Oncol. - 2007

Manuscript - No-Endpoint Endpoint - Other Analysis - GI - ACCENT

Normative data and clinically significant effect sizes for single-item numerical linear analogue self-assessment (LASA) scales

PubMed

PMC

QxMD

DOI

Google Scholar

Randomized Trial of FOLFOX Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair or Microsatellite Instability (ATOMIC, Alliance A021502)

Google Scholar

Sinicrope FA , Ou, F-S , Shi, Q , Nixon, A , Kabir Mody ... - ASCO - J. Clin. Oncol. - 2017

Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - GI - A021502

Lessons from Large Scale Collection of Patient Reported Outcomes: Implications for Big Data Aggregation and Analytics

PubMed

PMC

QxMD

DOI

Google Scholar

Sloan, Jeff A. , Halyard, Michele , El Naqa, Issam ... - - Int. J. Radiat. Oncol. Biol. Phys. - 2016

Manuscript - No-Endpoint Endpoint - Other Analysis - Health Outcome - N9741 , NCCTG-89-20-52

The ALTERNATE trial: assessing a biomarker driven strategy for the treatment of post-menopausal women with ER+/Her2− invasive breast cancer

PubMed

PMC

QxMD

DOI

Google Scholar

Suman, Vera Jean , Ellis, Matthew J. ... - - Chin Clin Oncol - 2015

Manuscript - No-Endpoint Endpoint - Trial-Description-Only Analysis - Breast - A011106

A phase I/randomized phase II study of MLN0128 vs. Pazopanib in patients with locally advanced/unresectable and/or metastatic sarcoma: Alliance A091304

Google Scholar

Tap, William , Mahoney, Michelle , Horvath, Elise ... - ASCO - J. Clin. Oncol. - 2016

Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - Experimental - A091304

A randomized phase II trial of vitamin D vs placebo in premenopausal women: CALGB 70806

Google Scholar

Wood, M. E. , Kinglsey, F. , Ambaye, A. B. , Yee, L. , Jung, S. J. ... - AACR - Cancer Res. - 2011

Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - Prevention - CALGB-70806

Change in mammographic density with metformin use: A companion study to NCIC study MA.32.

Google Scholar

Wood, Marie E. , Qin, Rui , Le-Petross, Huong T. , Hwang, E Shelley ... - ASCO - J. Clin. Oncol. - 2013

Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - Breast - A211201

Objective Measures of Performance Status in Cancer: A pilot Alliance study

Google Scholar

Wood, WA , Tan, X , Grover, NS , Stover, A , Kannappan, A ... - ASCO QCS - J Clin Oncol - 2018

Abstract - No-Endpoint Endpoint - Primary Analysis - Disparities - Pilot

Pathways: patient-centred decision counselling for women at risk of cancer-related infertility: a protocol for a comparative effectiveness cluster randomised trial

PubMed

PMC

QxMD

DOI

Google Scholar

Woodard, Terri Lynn , Hoffman, Aubri S , Crocker, Laura C ... - - BMJ Open - 2018

Manuscript - No-Endpoint Endpoint - Trial-Description-Only Analysis - ACS CCDRC - NCT03141437

PDIGREE: An adaptive phase 3 trial of PD-inhibitor nivolumab and Ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated REnal Cell CancEr (Alliance A031704)

Google Scholar

Zhang, Tian , Ballman, Karla , Choudhury, Atish , Chen, Ronald C. ... - ASCO - J Clin Oncol - 2019

Abstract - No-Endpoint Endpoint - Trial-Description-Only Analysis - GU - A031704